Sands Capital Ventures, LLC Long-Term Concentrated

CIK: 0001846444 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 14, 2025

Total Value ($000): $408,897 (100.0% shares, 0.0% debt)

Holdings (20)

KVYO KLAVIYO INC 25.5%
Value ($000) $104,201 Shares 3,443,515 Est. Cost $27.73 Unrealized +45.5%
NU NU HLDGS LTD 17.9%
Value ($000) $73,363 Shares 7,164,355 Est. Cost $10.60 Unrealized +11.5%
DASH DOORDASH INC 17.0%
Value ($000) $69,581 Shares 380,704 Est. Cost $191.28 Unrealized -1.7%
BBNX BETA BIONICS INC 9.3%
Value ($000) $37,990 Shares 3,103,782 Est. Cost $18.64 Unrealized 0.0%
IKT INHIBIKASE THERAPEUTICS INC 5.9%
Value ($000) $23,981 Shares 10,950,000 Est. Cost $2.49 Unrealized +0.7%
CPNG COUPANG INC 4.5%
Value ($000) $18,497 Shares 843,476 Est. Cost $24.45 Unrealized -5.0%
MNDY MONDAY COM LTD 3.0%
Value ($000) $12,136 Shares 49,908 Est. Cost $276.58 Unrealized -4.4%
DDOG DATADOG INC 2.9%
Value ($000) $11,700 Shares 117,930 Est. Cost $134.86 Unrealized -6.4%
IOT SAMSARA INC 2.4%
Value ($000) $9,714 Shares 253,432 Est. Cost $48.26 Unrealized -3.5%
TARS TARSUS PHARMACEUTICALS INC 2.1%
Value ($000) $8,733 Shares 170,000 Est. Cost $24.75 Unrealized +99.7%
TOST TOAST INC 1.7%
Value ($000) $6,986 Shares 210,611 Est. Cost $34.83 Unrealized +7.5%
CRWD CROWDSTRIKE HLDGS INC 1.3%
Value ($000) $5,486 Shares 15,560 Est. Cost $330.02 Unrealized +15.5%
ACRV ACRIVON THERAPEUTICS INC 1.1%
Value ($000) $4,309 Shares 2,122,605 Est. Cost $11.67 Unrealized -53.9%
TXG 10X GENOMICS INC 1.0%
Value ($000) $4,206 Shares 481,770 Est. Cost $51.88 Unrealized -75.7%
PATH UIPATH INC 1.0%
Value ($000) $4,077 Shares 395,855 Est. Cost $47.71 Unrealized -73.0%
SNOW SNOWFLAKE INC 1.0%
Value ($000) $3,921 Shares 26,828 Est. Cost $284.41 Unrealized -40.3%
ABOS ACUMEN PHARMACEUTICALS INC 0.9%
Value ($000) $3,759 Shares 3,417,075 Est. Cost $16.64 Unrealized -91.4%
BIOA BIOAGE LABS INC 0.7%
Value ($000) $2,957 Shares 786,353 Est. Cost $20.04 Unrealized -76.9%
CADL CANDEL THERAPEUTICS INC 0.6%
Value ($000) $2,293 Shares 405,837 Est. Cost $8.29 Unrealized -1.5%
TSHA TAYSHA GENE THERAPIES INC 0.2%
Value ($000) $1,008 Shares 724,873 Est. Cost $19.01 Unrealized -91.2%